Dr. Herrera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2106 Hilton Head Dr
Round Rock, TX 78664Phone+1 512-608-3835
Summary
- Dr. Larry Herrera is a Pediatrician and Physician/Scientist in Round Rock, TX. He received his medical degree from Texas A&M Health Science Center College of Medicine, completed a Fellowship in Pediatric Hematology-Oncology, and has been in practice 30 years. He also speaks multiple languages, including Spanish. He has been the Director of several Pediatric Hospital programs. He specializes in Urgent Care and Hospital Medicine and is experienced in grant writing.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 1994 - 1999
Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Pediatrics, 1991 - 1994
Texas A&M; Health Science Center College of MedicineClass of 1991
Certifications & Licensure
TX State Medical License 1992 - 2025
AZ State Medical License 2011 - 2015
NJ State Medical License 2008 - 2013
PA State Medical License 2005 - 2008- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Associate Professor of Pediatrics George Washington University, 2010-2012
- NIH Career Development Award National Institutes of Health, 2000-2008
- Governor Appointee to Texas Cancer Council State of Texas, 2000-2004
- Join now to see all
Clinical Trials
- Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2006 Feb 22
- Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 73 citationsA phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia.Larry Herrera, Bruce Bostrom, Lisa Gore, Eric Sandler, Glen Lew
Journal of Pediatric Hematology/oncology. 2009-12-01 - 67 citationsBCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.Tomasz Stoklosa, Tomasz Poplawski, Mateusz Koptyra, Margaret Nieborowska-Skorska, Grzegorz W. Basak
Cancer Research. 2008-04-15 - 18 citationsAnti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines.C. Stanciu-Herrera, C. Morgan, Larry Herrera
Leukemia Research. 2008-04-01
Grant Support
- Career Development AwardNIH2000–2005
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
